Naproxen sodium for OB/GYN use, with special reference to pain states: a review.
The effectiveness of naproxen sodium and its parent compound, naproxen, has been assessed in the treatment of a variety of obstetric and gynecologic problems, particularly pain states. This article summarizes the literature on the efficacy of the naproxen compounds in treatment of the following conditions: primary and secondary dysmenorrhea, insertion of a contraceptive intrauterine device, suction curettage, postpartum pain, pelvic inflammatory disease, gynecologic surgery, menorrhagia, premature labor and menopause. The data from the studies compiled demonstrate the usefulness of naproxen sodium or naproxen as an effective analgesic in treating pain and inflammation associated with these conditions.
D002986:Clinical Trials as Topic; D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007044:Hysterectomy; D007434:Intrauterine Devices; D007813:Laparotomy; D008593:Menopause / Q000187:drug effects; D008595:Menorrhagia / Q000188:drug therapy; D009288:Naproxen / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy*; D010149:Postoperative Pain / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy
D009288:Naproxen